Edwards Lifesciences's top three insider shareholders as of April 22, 2026 are Michael A Mussallem (Chairman Ceo, 4.04Mn shares), Michael A Mussallem (Chairman Ceo, 4.04Mn shares), Scott B. Ullem (Cvp, Chief Financial Officer, 266.32K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Michael A Mussallem | Chairman Ceo | 0 | 4,038,377 | 06 Nov, 2023 |
| Michael A Mussallem | Chairman Ceo | 0 | 4,038,377 | 06 Nov, 2023 |
| Scott B. Ullem | Cvp, Chief Financial Officer | 0 | 266,318 | 17 May, 2023 |
| Larry L Wood | Global President Tavr Surg | 206,900 | 0 | 18 Aug, 2025 |
| Larry L Wood | Global President Tavr Surg | 206,900 | 0 | 18 Aug, 2025 |
| Jean-Luc M Lemercier | Cvp, Emeacla And Japac | 184,686 | 0 | 08 Jul, 2024 |
| Jean-Luc M Lemercier | Cvp, Emeacla And Japac | 184,686 | 0 | 08 Jul, 2024 |
| Donald E Jr Bobo | Cvp,Strategy/Corp Development | 0 | 111,605 | 04 May, 2023 |
| Huimin Wang | Cvp, Japan Intercontinental | 99,381 | 0 | 08 Jul, 2022 |
| Huimin Wang | Cvp, Japan Intercontinental | 99,381 | 0 | 08 Jul, 2022 |
| Bernard J Zovighian | Ceo | 80,976 | 11,517 | 13 Feb, 2026 |
| Bernard J Zovighian | Ceo | 80,976 | 11,517 | 13 Feb, 2026 |
| Catherine M. Szyman | Cvp, Critical Care | 81,287 | 0 | 03 Sep, 2024 |
| Catherine M. Szyman | Cvp, Critical Care | 81,287 | 0 | 03 Sep, 2024 |
| Nicholas J Valeriani | - | 79,296 | 0 | 09 May, 2025 |
| Nicholas J Valeriani | - | 79,296 | 0 | 09 May, 2025 |
| Kieran Gallahue | - | 0 | 67,219 | 26 Feb, 2024 |
| Steven R Loranger | - | 65,054 | 0 | 09 May, 2025 |
| Scott B. Ullem | Cvp, Chief Financial Officer | 39,699 | 0 | 09 Apr, 2026 |
| Daniel J. Lippis | Cvp, Tavr | 33,934 | 0 | 06 Apr, 2026 |
| Daveen Chopra | Cvp, Tmtt Surgical | 32,201 | 0 | 11 Dec, 2025 |
| Martha H. Marsh | - | 31,880 | 0 | 15 May, 2023 |
| Heisz Leslie Stone | - | 30,948 | 0 | 12 Dec, 2025 |
| Donald E Jr Bobo | Cvp,Strategy/Corp Development | 21,266 | 0 | 02 Apr, 2026 |
| Wayne Markowitz | Cvp, Japac | 17,563 | 0 | 08 Dec, 2025 |
| Wayne Markowitz | Cvp, Japac | 17,563 | 0 | 08 Dec, 2025 |
| Robert W.A. Sellers | Svp, Corporate Controller | 17,081 | 0 | 13 May, 2024 |
| Robert W.A. Sellers | Svp, Corporate Controller | 17,081 | 0 | 13 May, 2024 |
| Paul A Laviolette | - | 14,301 | 0 | 09 May, 2025 |
| Annette Bruls | Cvp, Emeacla | 14,171 | 0 | 11 Jul, 2025 |
| Ramona Sequeira | - | 11,686 | 0 | 09 May, 2025 |
| Ramona Sequeira | - | 11,686 | 0 | 09 May, 2025 |
| Andrew M. Dahl | Svp, Corporate Controller | 9,089 | 0 | 23 Feb, 2026 |
| Leslie C. Davis | - | 6,583 | 0 | 09 May, 2025 |
| David T Feinberg | - | 5,836 | 0 | 09 May, 2025 |
| Kieran Gallahue | - | 4,682 | 0 | 09 May, 2025 |
| Michael A Mussallem | Chairman Ceo | 4,486 | 0 | 02 May, 2024 |
| Michael A Mussallem | Chairman Ceo | 4,486 | 0 | 02 May, 2024 |
| Bernard J Zovighian | Ceo | 0 | 3,268 | 07 May, 2024 |
| Bernard J Zovighian | Ceo | 0 | 3,268 | 07 May, 2024 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 09 Apr, 2026 | Scott B. Ullem | Common Stock | A | 13,000 | $59.26 | 52,699 | D | M |
| 09 Apr, 2026 | Scott B. Ullem | Common Stock | D | 4,676 | $80.50 | 48,023 | D | S |
| 09 Apr, 2026 | Scott B. Ullem | Common Stock | D | 8,324 | $79.79 | 39,699 | D | S |
| 09 Apr, 2026 | Scott B. Ullem | Employee Stock Option (Right to Acquire) | D | 13,000 | $0.00 | 13,000 | D | M |
| 06 Apr, 2026 | Daniel J. Lippis | Common Stock | A | 1,019 | $59.26 | 34,953 | D | M |
| 06 Apr, 2026 | Daniel J. Lippis | Common Stock | D | 1,019 | $80.98 | 33,934 | D | S |
| 06 Apr, 2026 | Daniel J. Lippis | Employee Stock Option (Right to Acquire) | D | 1,019 | $0.00 | 2,038 | D | M |
| 02 Apr, 2026 | Donald E Jr Bobo | Common Stock | A | 22,680 | $59.26 | 43,946 | D | M |
| 02 Apr, 2026 | Donald E Jr Bobo | Common Stock | D | 4,676 | $80.59 | 39,270 | D | S |
| 02 Apr, 2026 | Donald E Jr Bobo | Common Stock | D | 18,004 | $80.05 | 21,266 | D | S |
| 02 Apr, 2026 | Donald E Jr Bobo | Employee Stock Option (Right to Acquire) | D | 22,680 | $0.00 | 0 | D | M |
| 11 Mar, 2026 | Daniel J. Lippis | Common Stock | A | 1,019 | $59.26 | 34,953 | D | M |
| 11 Mar, 2026 | Scott B. Ullem | Common Stock | A | 13,000 | $59.26 | 52,699 | D | M |
| 11 Mar, 2026 | Daniel J. Lippis | Common Stock | D | 1,019 | $85.38 | 33,934 | D | S |
| 11 Mar, 2026 | Scott B. Ullem | Common Stock | D | 5,099 | $84.46 | 47,600 | D | S |
| 11 Mar, 2026 | Daniel J. Lippis | Employee Stock Option (Right to Acquire) | D | 1,019 | $0.00 | 3,057 | D | M |
| 11 Mar, 2026 | Scott B. Ullem | Common Stock | D | 7,901 | $85.21 | 39,699 | D | S |
| 11 Mar, 2026 | Scott B. Ullem | Employee Stock Option (Right to Acquire) | D | 13,000 | $0.00 | 26,000 | D | M |
| 02 Mar, 2026 | Donald E Jr Bobo | Common Stock | A | 11,340 | $59.26 | 32,606 | D | M |
| 02 Mar, 2026 | Donald E Jr Bobo | Common Stock | D | 11,340 | $85.93 | 21,266 | D | S |